Orally administered microencapsulated lysozyme downregulates serum AGE and reduces the severity of early-stage diabetic nephropathy.
about
Uremic Toxicity of Advanced Glycation End Products in CKD.IL-1β, RAGE and FABP4: targeting the dynamic trio in metabolic inflammation and related pathologies.New drug-targeting strategy from beneath the shell of egg.Role of advanced glycation endproducts and potential therapeutic interventions in dialysis patients.Molecular strategies to prevent, inhibit, and degrade advanced glycoxidation and advanced lipoxidation end products.Human recombinant lysozyme downregulates advanced glycation endproduct-induced interleukin-6 production and release in an in-vitro model of human proximal tubular epithelial cells.Microencapsulation of bioactive principles with an airless spray-gun suitable for processing high viscous solutions.Recombination and functional studies of a dual-action peptide for diabetes.
P2860
Q36514906-90AC7856-4BC9-4CA2-ADAF-A570EC9A2B9FQ37305013-EB5F53CB-0D8A-44F1-B1F8-8762B305EF2BQ37788223-A02BEC10-3882-415D-B38B-32A0E3CCF11AQ38006722-2265A3AB-AB17-4536-A5D9-3630F6228ED8Q38096444-897FC487-D4C3-41DE-A65C-48322D25BE6DQ39027326-7A23C094-CAB3-4A9C-B766-AA7C0455BEE1Q39870909-9A761F0B-8D7E-47CB-8E9D-857F6074E99AQ44227850-E873640D-4053-4927-BE29-ECBE8BD9C40B
P2860
Orally administered microencapsulated lysozyme downregulates serum AGE and reduces the severity of early-stage diabetic nephropathy.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Orally administered microencap ...... ly-stage diabetic nephropathy.
@en
Orally administered microencap ...... ly-stage diabetic nephropathy.
@nl
type
label
Orally administered microencap ...... ly-stage diabetic nephropathy.
@en
Orally administered microencap ...... ly-stage diabetic nephropathy.
@nl
prefLabel
Orally administered microencap ...... ly-stage diabetic nephropathy.
@en
Orally administered microencap ...... ly-stage diabetic nephropathy.
@nl
P2093
P1476
Orally administered microencap ...... ly-stage diabetic nephropathy.
@en
P2093
P304
P356
10.1016/J.DIABET.2008.05.009
P433
P577
2008-10-15T00:00:00Z